Skip to main content
logo
Goldenwell Biotech, Inc. (GWLL)
OTCMKTS · Delayed Price · Currency is USD
0.7700
0.00 (0.00%)
At close: Aug 5, 2026

Goldenwell Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00000.050.02
Revenue Growth
-60.43%-60.43%-92.43%-96.16%199.37%-
Gross Profit
-0.17-0.17000.030.01
Operating Income
-0.28-0.29-0.12-0.12-0.99-0.12
Net Income
-0.28-0.3-0.13-0.12-0.99-0.12
Earnings Per Share
-0.00-0.00-0.00-0.00-0.01-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.030.050.050.050.21
Total Debt
0.280.280.270.140.050.05
Net Cash (Debt)
-0.27-0.25-0.22-0.0900.17
Net Cash Growth
-----99.62%-33.31%
Net Cash Per Share
-0.00-0.00-0.00-0.000.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0-0.02-0.12-0.11-1.07-0.21
Free Cash Flow
-0-0.02-0.12-0.11-1.07-0.21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--46.04%36.27%52.69%52.53%
Operating Margin
-514490.91%-523765.46%-88559.71%-6308.61%-2060.89%-740.70%
Pretax Margin
-500983.64%-539038.18%-94602.88%-6392.21%-2060.87%-732.64%
Profit Margin
-500983.64%-539038.18%-94602.88%-6392.21%-2060.87%-732.64%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1386000.005220000.00142446.043159.80610.98-